Literature DB >> 18613245

Estimation of risk factor associations when the response is influenced by medication use: an imputation approach.

Robyn L McClelland1, Richard A Kronmal, Jeffrey Haessler, Roger S Blumenthal, David C Goff.   

Abstract

When the outcome of interest is a quantity whose value may be altered through the use of medications, estimation of associations with this outcome is a challenging statistical problem. For participants taking medication the treated value is observed, but the underlying 'untreated' value may be the measure that is truly of interest. Problematically, those with the highest untreated values may have some of the lowest observed measurements due to the effectiveness of medications. In this paper we propose an approach in which we parametrically estimate the underlying untreated variable of interest as a function of the observed treated value, and dose and type of medication. Multiple imputation is used to incorporate the variability induced by the estimation. We show that this approach yields more realistic parameter estimates than other more traditional approaches to the problem and that study conclusions may be altered in a meaningful way by using the imputed values. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18613245      PMCID: PMC2829271          DOI: 10.1002/sim.3341

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  15 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Dyslipidemia management in adults with diabetes.

Authors:  Steven M Haffner
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

3.  The use of regression models for medians when observed outcomes may be modified by interventions.

Authors:  Ian R White; Ilona Koupilova; James Carpenter
Journal:  Stat Med       Date:  2003-04-15       Impact factor: 2.373

Review 4.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

5.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure.

Authors:  Martin D Tobin; Nuala A Sheehan; Katrina J Scurrah; Paul R Burton
Journal:  Stat Med       Date:  2005-10-15       Impact factor: 2.373

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more
  16 in total

1.  A systematic assessment of the association of polysomnographic indices with blood pressure: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Dennis A Dean; Rui Wang; David R Jacobs; Daniel Duprez; Naresh M Punjabi; Phyllis C Zee; Steven Shea; Karol Watson; Susan Redline
Journal:  Sleep       Date:  2015-04-01       Impact factor: 5.849

2.  A method to account for covariate-specific treatment effects when estimating biomarker associations in the presence of endogenous medication use.

Authors:  Andrew J Spieker; Joseph Ac Delaney; Robyn L McClelland
Journal:  Stat Methods Med Res       Date:  2016-12-22       Impact factor: 3.021

3.  Methods for estimation of disparities in medication use in an observational cohort study: results from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Robyn L McClelland; Neal W Jorgensen; Wendy S Post; Moyses Szklo; Richard A Kronmal
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-02-04       Impact factor: 2.890

4.  Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication use.

Authors:  Andrew J Spieker; Joseph A C Delaney; Robyn L McClelland
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-09-30       Impact factor: 2.890

5.  Baseline depressive symptoms are not associated with clinically important levels of incident hypertension during two years of follow-up: the multi-ethnic study of atherosclerosis.

Authors:  Joseph A C Delaney; Bruce E Oddson; Holly Kramer; Steven Shea; Bruce M Psaty; Robyn L McClelland
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

6.  Periodic limb movements during sleep and prevalent hypertension in the multi-ethnic study of atherosclerosis.

Authors:  Brian B Koo; Stefan Sillau; Dennis A Dean; Pamela L Lutsey; Susan Redline
Journal:  Hypertension       Date:  2014-10-06       Impact factor: 10.190

7.  Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Pathmaja Paramsothy; Robert Knopp; Alain G Bertoni; Michael Y Tsai; Tessa Rue; Susan R Heckbert
Journal:  Metabolism       Date:  2009-02       Impact factor: 8.694

8.  Age-modification of lipoprotein, lipid, and lipoprotein ratio-associated risk for coronary artery calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Pathmaja Paramsothy; Ronit Katz; David S Owens; Gregory L Burke; Jeffrey L Probstfield; Kevin D O'Brien
Journal:  Am J Cardiol       Date:  2009-12-22       Impact factor: 2.778

9.  Age modification of the association of lipoprotein, lipid, and lipoprotein ratio with carotid intima-media thickness (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Pathmaja Paramsothy; Ronit Katz; David S Owens; Gregory L Burke; Jeffrey L Probstfield; Kevin D O'Brien
Journal:  Am J Cardiol       Date:  2011-12-10       Impact factor: 2.778

10.  Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis.

Authors:  Neal W Jorgensen; Christopher T Sibley; Robyn L McClelland
Journal:  BMC Med Res Methodol       Date:  2013-06-21       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.